- Home
- DMRC vs CATX Comparison
DMRC vs CATX Comparison
Compare DMRC & CATX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMRC
- CATX
- Stock Information
- Founded
- DMRC 2008
- CATX 1983
- Country
- DMRC United States
- CATX United States
- Employees
- DMRC N/A
- CATX N/A
- Industry
- DMRC EDP Services
- CATX Medical/Dental Instruments
- Sector
- DMRC Technology
- CATX Health Care
- Exchange
- DMRC Nasdaq
- CATX Nasdaq
- Market Cap
- DMRC 275.4M
- CATX 239.0M
- IPO Year
- DMRC N/A
- CATX N/A
- Fundamental
- Price
- DMRC $13.70
- CATX $3.68
- Analyst Decision
- DMRC Strong Buy
- CATX Strong Buy
- Analyst Count
- DMRC 1
- CATX 11
- Target Price
- DMRC $30.00
- CATX $12.90
- AVG Volume (30 Days)
- DMRC 136.4K
- CATX 1.4M
- Earning Date
- DMRC 08-12-2025
- CATX 08-11-2025
- Dividend Yield
- DMRC N/A
- CATX N/A
- EPS Growth
- DMRC N/A
- CATX N/A
- EPS
- DMRC N/A
- CATX N/A
- Revenue
- DMRC $37,848,000.00
- CATX $1,471,000.00
- Revenue This Year
- DMRC N/A
- CATX N/A
- Revenue Next Year
- DMRC $4.21
- CATX N/A
- P/E Ratio
- DMRC N/A
- CATX N/A
- Revenue Growth
- DMRC 2.44
- CATX N/A
- 52 Week Low
- DMRC $10.44
- CATX $1.60
- 52 Week High
- DMRC $48.32
- CATX $16.55
- Technical
- Relative Strength Index (RSI)
- DMRC 57.16
- CATX 57.83
- Support Level
- DMRC $13.04
- CATX $3.21
- Resistance Level
- DMRC $13.25
- CATX $4.44
- Average True Range (ATR)
- DMRC 0.64
- CATX 0.39
- MACD
- DMRC 0.08
- CATX -0.05
- Stochastic Oscillator
- DMRC 84.02
- CATX 45.71
About DMRC Digimarc Corporation
Digimarc Corp is engaged in digital watermarking technologies. The Digimarc Illuminate platform is a distinctive software as a service (SaaS) cloud-based platform for digital connectivity that provides the tools for the application of digital watermarks and dynamic Quick Response (QR) codes, software (digital twins) that enables various systems and devices to interact with those data carriers and a centralized platform for capturing insights about digital interactions and automating activities based on that information. The company generates revenue through commercial and government applications of its technology. The company derives its revenue from software development services, subscriptions for products and related services, and licensing of patents.
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.